Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis

被引:7
|
作者
Feng, Lijuan [1 ]
Chen, Qianjuan [1 ]
Huang, Linjie [1 ]
Long, Liling [1 ,2 ,3 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning, Guangxi, Peoples R China
[2] Gaungxi Med Univ, Key Lab Early Prevent & Treatment Reg High Frequen, Minist Educ, Nanning, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Guangxi Key Lab Immunol & Metab Liver Dis, Nanning, Guangxi, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
hepatocellular carcinoma; radiomics; transarterial chemoembolization; tumor response; systematic review; ONCOLOGY;
D O I
10.3389/fonc.2023.1194200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeTo examine the methodological quality of radiomics-related studies and evaluate the ability of radiomics to predict treatment response to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). MethodsA systematic review was performed on radiomics-related studies published until October 15, 2022, predicting the effectiveness of TACE for HCC. Methodological quality and risk of bias were assessed using the Radiomics Quality Score (RQS) and Quality Assessment of Diagnostic Accuracy Studies-2 tools, respectively. Pooled sensitivity, pooled specificity, and area under the curve (AUC) were determined to evaluate the utility of radiomics in predicting the response to TACE for HCC. ResultsIn this systematic review, ten studies were eligible, and six of these studies were used in our meta-analysis. The RQS ranged from 7-21 (maximum possible score: 36). The pooled sensitivity and specificity were 0.89 (95% confidence interval (CI) = 0.79-0.95) and 0.82 (95% CI = 0.64-0.92), respectively. The overall AUC was 0.93 (95% CI = 0.90-0.95). ConclusionRadiomics-related studies evaluating the efficacy of TACE in patients with HCC revealed promising results. However, prospective and multicenter trials are warranted to make radiomics more feasible and acceptable.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis
    Shushan Yan
    Donghua Xu
    Beicheng Sun
    Digestive Diseases and Sciences, 2013, 58 : 2107 - 2113
  • [22] Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis
    Yan, Shushan
    Xu, Donghua
    Sun, Beicheng
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (11) : 3026 - 3031
  • [23] Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-Analysis
    Liao, Mingheng
    Huang, Jiwei
    Zhang, Tao
    Wu, Hong
    PLOS ONE, 2013, 8 (07):
  • [24] Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis
    Shushan Yan
    Donghua Xu
    Beicheng Sun
    Digestive Diseases and Sciences, 2012, 57 : 3026 - 3031
  • [25] Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis
    Yan, Shushan
    Xu, Donghua
    Sun, Beicheng
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (07) : 2107 - 2113
  • [26] Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma
    Popovic, Peter
    Leban, Ana
    Kregar, Klara
    Garbajs, Manca
    Dezman, Rok
    Bunc, Matjaz
    RADIOLOGY AND ONCOLOGY, 2018, 52 (01) : 14 - 22
  • [27] Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(R) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
    Liang, Bin
    Makamure, Joyman
    Shu, Shenglei
    Zhang, Lijie
    Sun, Tao
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization
    Kim, Beom Kyung
    Kim, Kyung Ah
    An, Chansik
    Yoo, Eun Jin
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    Kim, Myeong-Jin
    LIVER INTERNATIONAL, 2015, 35 (06) : 1722 - 1730
  • [29] Meta-analysis of transarterial chemoembolization combined with cryoablation vs transarterial chemoembolization alone for ≥ 5 cm hepatocellular carcinoma
    Cheng, Jie-Fei
    Sun, Qiu-Lian
    Tang, Ling
    Xu, Xin-Jian
    Huang, Xiang-Zhong
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06) : 2793 - 2803
  • [30] Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization
    Bolog, Nicolae
    Pfammatter, Thomas
    Muellhaupt, Beat
    Andreisek, Gustav
    Weishaupt, Dominik
    ABDOMINAL IMAGING, 2008, 33 (03): : 313 - 323